Literature DB >> 29249194

Multi-functional magnetic nanoparticles as an effective drug carrier for the controlled anti-tumor treatment.

Zhi Li1, Junya Zhang1, Xiaonan Guo1, Xinhong Guo1, Zhenzhong Zhang1.   

Abstract

Because of the complications and mutability of cancers, combination of chemotherapy and other therapy with multi-mechanisms would be a bright future for the treatment of cancer. Thus, development of multi-functional tumor-targeted drug delivery systems with two or more than two functions should be of great significance. In the study, the Fe3O4@C nanoparticles linked with thermoresponsive copolymer (MTC-NPs) were synthesized, after that, the magnetic properties and photothermal effects of MTC NPs were evaluated. Compared to the pure water, MTC-NPs absorbed more energy and transform it into heat under the 808 nm laser irradiation, and the temperature could increase over 60℃. In addition, the grafted copolymer with coil-to-globule transition acts as a gatekeeper for the temperature-controlled release of mitoxantrone molecules. The super paramagnetic behavior of MTC-NPs certified by the hysteresis loop gives a negligible coercivity at room temperature. Both in vitro and in vivo studies confirmed that the synergistic combination of magnetic targeting, drug controlled release, and thermochemotherapy improve the anti-tumor efficacy with lower side effects. This nanoparticle is a great potential drug carrier in anti-tumor drugs, which can improve the effect of hyperthermia, increase target distribution in tumor, and enhance curative effect for tumor while reducing normal tissue toxicity.

Entities:  

Keywords:  Nanoparticles drug delivery; drug controlled release; drug delivery; magnetic properties; photothermal effects

Mesh:

Substances:

Year:  2017        PMID: 29249194     DOI: 10.1177/0885328217748023

Source DB:  PubMed          Journal:  J Biomater Appl        ISSN: 0885-3282            Impact factor:   2.646


  1 in total

1.  Efficient uptake and retention of iron oxide-based nanoparticles in HeLa cells leads to an effective intracellular delivery of doxorubicin.

Authors:  R C Popescu; D Savu; I Dorobantu; B S Vasile; H Hosser; A Boldeiu; M Temelie; M Straticiuc; D A Iancu; E Andronescu; F Wenz; F A Giordano; C Herskind; M R Veldwijk
Journal:  Sci Rep       Date:  2020-06-29       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.